An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimen...

por Evitt, Lee A., Nanji, Sakina, Grove, Richard A., Okoli, Chinyere, van Wyk, Jean, Snedecor, Sonya J.
Publicado 2023

898. Effectiveness and Tolerability of DTG + 3TC in Clinical Practice: Evidence in PLHIV from Real-world Data

por Evitt, Lee A, Kumar, Rahul, Kamath, Rahul, Jha, Diwakar, Parks, Daniel, van Wyk, Jean A, de Ruiter, Annemiek
Publicado 2021

Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study

por Engelkes, Marjolein, Baan, Esme J., de Ridder, Maria A. J., Svensson, Elisabeth, Prieto‐Alhambra, Daniel, Lapi, Francesco, Giaquinto, Carlo, Picelli, Gino, Boudiaf, Nada, Albers, Frank, Evitt, Lee A., Cockle, Sarah, Bradford, Eric, Van Dyke, Melissa K., Suruki, Robert, Rijnbeek, Peter, Sturkenboom, Miriam C. J. M., Janssens, Hettie M., Verhamme, Katia M. C.
Publicado 2020